Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Granules India Merger & Restructuring

Granules India incorporated a wholly owned Mexican subsidiary, Triton Farmaceutica S.A. de C.V., to manufacture and distribute pharmaceuticals in Mexico. Operations have yet to commence.

Source

BSE filing, NSE: GRANULES. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Granules India Ltd: key numbers

Share price
₹840.45
Market cap
₹20,826 Cr
Revenue (annual)
₹5,366 Cr
Net profit (annual)
₹595.0 Cr
P/E (TTM)
31.4×Sector 46.1×
Promoter holding
37.39%-0.63% QoQ
FII holding
20.25%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Granules India Ltd

All →
11:42 IST BSE
Convertible Warrants

Granules India Convertible Warrants

Promoter group members Uma Devi, Priyanka, Pragnya and Harsha were allotted 2,49,82,906 Granules India shares on warrant conversion. The balance payment totals about ₹1,096.13 crore.

Value
₹1,096 Cr

Other merger & restructuring announcements

All →
19:53 IST NSE
Merger & RestructuringEmkay Global Financial Services Ltd EMKAY

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value
₹30.00 Cr
Execution
Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals